Changes are coming to our lives and world that may rival the industrial and internet revolutions. Jeremy Schwartz and Kara Marciscano discuss the BioRevolution already underway and identify the range of business sectors we believe are best positioned to benefit.
Many investors have preconceived notions about hedging currency risk in their international equity investments. Jeremy Schwartz and Jeff Weniger seek to challenge the status quo, making the case for hedging your currency bets.
We believe that there is an opportunity in the current quality market that should not be overlooked. Jeremy Schwartz explains how investors can seek to take advantage of this opportunity.
Jeff Weniger boils down just exactly what the “quality” factor means and why he believes there is opportunity in quality stocks in the post-pandemic market.
At WisdomTree, we’ve preached the merits of quality exposure through U.S. markets for a long time. We believe there is now an historic opportunity to access quality in developed international markets. Brian Manby discusses.
Many investors have behavioral biases that may cause them to be under-exposed to quality in their portfolios. Matt Wagner makes the case for tilting toward quality in today’s market environment.
After a decade of growth outperformance, value has taken over. For investors seeking value-like valuations with an investment process that favors quality, Jeremy Schwartz makes the case to consider our quality dividend growth Fund (DGRW).
